Live News • Jul 07
Grey Matters Health Unveils First Brain-Only PET Scanner at New Florida Clinic Grey Matters Health has received delivery of a brain-dedicated PET scanning system for its upcoming NovaScan Neuroimaging Clinic in Florida, which is expected to be the first U.S. site offering brain-only PET scans focused on early Alzheimer’s and other neurodegenerative disease detection.
The system is described as providing high-quality brain imaging with lower radiation exposure, and eligible patients are expected to have access through insurance coverage, which could support clinic utilization rather than relying solely on out-of-pocket payments.
Grey Matters Health shares last traded at CA$0.48, with the stock down about 20% year to date, indicating that the market has not reflected any long-term impact from the NovaScan clinic launch in the share price.
The key takeaway is that Grey Matters Health is moving from concept to operating assets, while execution risk around clinic ramp-up, patient volumes and practical reimbursement remains central to the story. Announcement • Jun 19
Grey Matters Health Inc. announced that it has received CAD 1.25 million in funding On June 18, 2026, Grey Matters Health Inc. closed the transaction. The company issued 1,875,000 units at an issue price of CAD 0.40 for gross proceeds of CAD 750,000 in its final tranche. The closing of the second tranche brings the financing to a total of CAD 1,250,000 from the sale of 3,125,000 units, including the closing of the first tranche. Certain insiders of the company participated in the second tranche of the offering in the amount of CAD 449,000. The company paid cash finder’s fees of CAD 28,000 and issued 70,000 finders warrants pertaining to the second tranche of the offering. The securities issued will be subject to a statutory hold period of four months plus a day from the date of issuance in accordance with applicable Canadian securities legislation. New Risk • Apr 30
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Canadian stocks, typically moving 18% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Shareholders have been substantially diluted in the past year (88% increase in shares outstanding). Revenue is less than US$1m. Market cap is less than US$10m (CA$1.82m market cap, or US$1.34m). Minor Risk Share price has been volatile over the past 3 months (18% average weekly change). 
